SportPharma Pepti-Lean Clinical Trials and Studies
SportPharma Pepti-Lean Information
SportPharma Pepti-Lean Clinical Trials and Studies
A number of studies performed on animals have demonstrated the ability of certain plant and animal proteins, such as used in SportPharma Pepti-Lean, to reduce blood fat (e.g., triglyceride) levels. In particular, small peptides formed following the digestion of these proteins appeared to have such beneficial effects. These clinically researched peptides are the basis of the proprietary peptide mixture found in Pepti-Lean.
The scientists performing the aforementioned studies thought that the peptides might be useful in reducing the risk of cardiovascular disease and obesity in humans. SportPharma Pepti-Lean studies on animals, and later humans, showed that they were correct in their assumption. By blocking fat absorption and directing fat away from storage and toward fat-burning (i.e., energy-supplying) pathways, these peptides can help reduce body fat.
In controlled trials involving humans (discussed below) as well as animals (e.g., Kagawa et al., Life Sciences, 58: 1745-1755), the peptides found in Pepti-Lean have been found to prevent fat from being absorbed into the bloodstream and help clear away the fat that does get absorbed so that it isn't stored as body fat.
In a double-blind study performed on 25 healthy adults, subjects were given capsules containing 100 mg of the fat-metabolizing peptides or a placebo. Capsules were taken during or after breakfast and dinner for a total of 600 mg or 1.2 g daily (low- or high-dose groups, respectively).
Both groups lost body fat by 1 month into the study. The researchers believed that the peptides in SportPharma Pepti-Lean prevented fat consumed by the subjects from being absorbed and accelerated the breakdown of stored body fat. Some subjects experienced a loss of more than 3% in percentage body fat, with those consuming the higher dose (1.2 grams per day spread over breakfast and dinner) tending to lose the most fat. Remarkably, the subjects were not following restricted diets; they were following ordinary eating plans containing their favorite foods.
In a similar study published in the Journal of Nutrition (Kagawa et al. 128: 56-60), the fat-metabolizing peptides were found to suppress the elevation in blood fat levels typically found following a high-fat meal. The researchers also reported studies indicating that repeated consumption of the fat-metabolizing peptides (like those in Pepti-Lean) stimulated the burning (oxidation) of fat in the liver. Whatever the mechanism, it was clear to the authors of the study that these peptides may be of use in preventing body fat gain.
There may have been aditional and more specific Pepti-Lean studies, but their criteria did not match those of a fully controlled study.
